Diabetic Footwear

Technology Outline

The therapeutic footwear with a full length PU foam inner sole to cradle and support the foot; PU molded outer sole with extra depth to accommodate layers of foams and having tread patterns selectively provided for better grip and traction; an upper to accommodate feet of varying volumes; counter stiffener along with padded ankle support was constructed.

Salient Features/ Highlights/ Advantages

This footwear was developed for prevention of foot complications in Persons with Diabetes. The footwear highlights the use of biomechanical principles in designing the correct footwear and materials for satisfying the requirements of scientifically appropriate footwear for diabetics to provide better shock absorption, reduced friction, better comfort and wear properties and most importantly helps in redistributing pressure uniformly on the plantar surface of the footto prevent callus and ulcer formation.

Business Case and Translation Status

• Status of commercialization : This technology has been already commercialized
• Licensed to one client
• Major Raw Materials to be utlilized: Leather, Polyethylene and polyurethane (PU)
• Validation level: It is a matter of great pleasure and pride that 11DIASTEP11 is now commercialized by Mis M V Health Care Pvt. Ltd. and thousands of patients have benefitted from this footwear
• Handholding support: Training, Demonstration, Technology Document, Trouble Shooting, Technology Implementation
• Techno-Economics :
• Capital investment of footwear unit is Rs. 1.5 Cr to 2.25 Cr and that of sole manufacturing unit is Rs. 1.5 Cr to 6.5 Cr; Payback period is 5 years.